365 related articles for article (PubMed ID: 20685626)
1. Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.
Salem AH; Elkhatib WF; Ahmed GF; Noreddin AM
J Chemother; 2010 Aug; 22(4):238-42. PubMed ID: 20685626
[TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin and biofilm production by coagulase-negative staphylococci.
Pérez-Giraldo C; Gonzalez-Velasco C; Sánchez-Silos RM; Hurtado C; Blanco MT; Gómez-García AC
Chemotherapy; 2004 Jun; 50(2):101-4. PubMed ID: 15211086
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy.
Blanco AR; Sudano Roccaro A; Spoto CG; Papa V
Curr Eye Res; 2013 Aug; 38(8):811-6. PubMed ID: 23534928
[TBL] [Abstract][Full Text] [Related]
4. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Parra-Ruiz J; Vidaillac C; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
6. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
Luther MK; Mermel LA; LaPlante KL
Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
[TBL] [Abstract][Full Text] [Related]
7. Discovery of quinoline small molecules with potent dispersal activity against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy.
Abouelhassan Y; Garrison AT; Burch GM; Wong W; Norwood VM; Huigens RW
Bioorg Med Chem Lett; 2014 Nov; 24(21):5076-80. PubMed ID: 25264073
[TBL] [Abstract][Full Text] [Related]
8. Halogenated quinolines discovered through reductive amination with potent eradication activities against MRSA, MRSE and VRE biofilms.
Basak A; Abouelhassan Y; Huigens RW
Org Biomol Chem; 2015 Nov; 13(41):10290-4. PubMed ID: 26414088
[TBL] [Abstract][Full Text] [Related]
9. Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).
Knafl D; Tobudic S; Cheng SC; Bellamy DR; Thalhammer F
Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):677-680. PubMed ID: 27896496
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
Wiederhold NP; Coyle EA; Raad II; Prince RA; Lewis RE
J Antimicrob Chemother; 2005 May; 55(5):792-5. PubMed ID: 15814598
[TBL] [Abstract][Full Text] [Related]
11. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Proksch JW; Ward KW
J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
[TBL] [Abstract][Full Text] [Related]
12. Anti-biofilm efficacy of silver nanoparticles against MRSA and MRSE isolated from wounds in a tertiary care hospital.
Ansari MA; Khan HM; Khan AA; Cameotra SS; Alzohairy MA
Indian J Med Microbiol; 2015; 33(1):101-9. PubMed ID: 25560011
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5-aminolevulinic acid-mediated photodynamic therapy on antibiotic-resistant staphylococcal biofilm: an in vitro study.
Li X; Guo H; Tian Q; Zheng G; Hu Y; Fu Y; Tan H
J Surg Res; 2013 Oct; 184(2):1013-21. PubMed ID: 23622723
[TBL] [Abstract][Full Text] [Related]
14. Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.
Luther MK; LaPlante KL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7790-4. PubMed ID: 26369963
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
Podos SD; Thanassi JA; Leggio M; Pucci MJ
Antimicrob Agents Chemother; 2012 Jul; 56(7):3812-8. PubMed ID: 22547614
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Nomura S; Hanaki H; Unemi N
Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of different bioactive glass S53P4 formulations in biofilm eradication and the impact of pH and osmotic pressure.
Müller N; Kollert M; Trampuz A; Gonzalez Moreno M
Colloids Surf B Biointerfaces; 2024 Jul; 239():113940. PubMed ID: 38744081
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antistaphylococcal activity of marine pyrrole alkaloid derivatives.
Rane RA; Sahu NU; Shah CP; Shah NK
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):401-7. PubMed ID: 23663080
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model.
Lister PD
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S33-8. PubMed ID: 11249827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
